The Short-Term Efficacy of Novel No-Touch Combined Directional Perfusion Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma with Cirrhosis

Abstract Background No-touch combined directed perfusion radiofrequency ablation (NTDP-RFA) is a new technique for the treatment of hepatocellular carcinoma (HCC). The purpose of this study was to evaluate the short-term efficacy of this new technique for the treatment of small HCC with cirrhosis. Methods From January 2017 to March 2018, 56 consecutive patients treated with NTDP-RFA at our center were enrolled in this retrospective study. All NTDP-RFA procedures involved the use of internally cooled wet electrodes with a directional injection function, which can perform both intraelectrode cooling and extraelectrode saline perfusion. Survival curves were analyzed using Kaplan–Meier methods, and Cox proportional hazards regression analyses were used to assess predictors of tumor progression and overall survival. Operative characteristics and complications were also assessed. Results No technical failure occurred, and the complete ablation rate after single NTDP-RFA treatment was 98.2%. The median tumor diameter and ablation time were 26 (18.0 − 28.0) mm and 8 (6 – 8) min, respectively. Mild complications occurred in five patients (8.9%) postoperatively, and the median hospital stay was 4 (4 − 5) days. In the 18 patients (32.1%) with poor liver function reserve (indocyanine green retention rate at 15 min > 15%, their liver function returned to normal on the third day after the postoperation. The 1- and 2-year local and distant progression rates were 1.7%, 7.1%, 3.5% and 10.7%, respectively. Conclusions NTDP-RFA in the treatment of small HCC with cirrhosis has a low incidence of complications and provides a high survival rate without local tumor progression.

[1]  V. Shelat,et al.  Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  J. Tani,et al.  Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients , 2019, Liver Cancer.

[3]  J. Shindoh,et al.  No‐touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  V. Bourcier,et al.  Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term Results , 2018, Liver Cancer.

[5]  L. Boussel,et al.  No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm. , 2018, Journal of hepatology.

[6]  P. Nahon,et al.  Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. , 2017, Journal of hepatology.

[7]  Yoshiyuki Suzuki,et al.  Potential of a no‐touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[8]  D. Lu,et al.  Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier? , 2016, Journal of vascular and interventional radiology : JVIR.

[9]  P. Nahon,et al.  Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results. , 2016, Radiology.

[10]  A. Hocquelet,et al.  Aggressive Intrasegmental Recurrence of Periportal Hepatocellular Carcinoma after Radiofrequency Ablation: Role of Ablative Technique and Heat-Sink Effect? , 2015, Radiology.

[11]  Y. Paik,et al.  Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance. , 2015, Radiology.

[12]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Journal of vascular and interventional radiology : JVIR.

[13]  F. Xia,et al.  A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. , 2012, Journal of hepatology.

[14]  Sheng-Nan Lu,et al.  Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. , 2012, Journal of hepatology.

[15]  M. Makuuchi,et al.  Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. , 2009, Journal of hepatology.

[16]  E. Hahn,et al.  Percutaneous Ultrasound-Guided Radiofrequency Ablation (RFA) Using Saline-Perfused (Wet) Needle Electrodes for the Treatment of Hepatocellular Carcinoma - Long Term Experience , 2007, Ultraschall in der Medizin.

[17]  Young Hun Choi,et al.  Switching Monopolar Radiofrequency Ablation Technique Using Multiple, Internally Cooled Electrodes and a Multichannel Generator: Ex Vivo and In Vivo Pilot Study , 2007, Investigative radiology.

[18]  W. Lau,et al.  Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular Carcinoma: A Prospective Randomized Trial , 2007, Annals of surgery.

[19]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[20]  L. Ellis,et al.  Significant Long-Term Survival After Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Patients with Cirrhosis , 2005, Annals of Surgical Oncology.

[21]  Wei Yang,et al.  Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process. , 2004, Radiology.

[22]  Jae Young Lee,et al.  Saline-Enhanced Hepatic Radiofrequency Ablation Using a Perfused-Cooled Electrode: Comparison of Dual Probe Bipolar Mode with Monopolar and Single Probe Bipolar Modes , 2004, Korean journal of radiology.

[23]  B. Choi,et al.  A Comparative Experimental Study of the In-vitro Efficiency of Hypertonic Saline-Enhanced Hepatic Bipolar and Monopolar Radiofrequency Ablation , 2003, Korean journal of radiology.

[24]  Carlo Bartolozzi,et al.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. , 2003, Radiology.

[25]  W. Lau,et al.  Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma: A Review and Look Into the Future , 2003, Annals of surgery.

[26]  G. Dodd,et al.  Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. , 2001, AJR. American journal of roentgenology.

[27]  R E Lenkinski,et al.  Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. , 2001, Radiology.

[28]  A. Güemes,et al.  Hepatic lesion ablation with bipolar saline-enhanced radiofrequency in the audible spectrum. , 1999, Academic radiology.

[29]  O. Seror,et al.  Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC. , 2017, Journal of hepatology.

[30]  V. Mazzaferro,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, European journal of cancer.

[31]  J. Bruix,et al.  Novel advancements in the management of hepatocellular carcinoma in 2008. , 2008, Journal of hepatology.

[32]  ORIGINAL ARTICLE – GASTROINTESTINAL ONCOLOGY Viable Tumor Tissue Adherent to Needle Applicators after Local Ablation: A Risk Factor for Local Tumor Progression , 2022 .